EMA Backs Approval of Elahere for Ovarian Cancer ...Middle East

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( EMA Backs Approval of Elahere for Ovarian Cancer )

Also on site :

• Morning Report — Texas braces for more flood danger after Hill Country tragedy 
• Bangladesh lawyers challenge ex-PM Hasina’s murder trial charges
• Ukraine plagued by ‘palace politics’ and purges – Economist